Amplia Therapeutics Investor Briefing – 21 October
Amplia Therapeutics (ASX: ATX) Webcast Replay
Amplia Therapeutics (ASX: ATX) is an Australian pharmaceutical company developing new drugs for cancer and fibrosis.
As a part of our ‘Meet the CEOs’ series, Chief Executive Officer Dr John Lambert provides valuable insights to the company, key markets and industry, and company’s future prospects.
Recorded on 21 October 2020 at 12pm (AEDT).